Novartis signs $840M pact with IFM Due amid fallout from AveXis deal

As Swiss drug giant Novartis AG deals with continuing fallout from a data manipulation controversy related to its acquisition of a drug startup AveXis, it’s considering acquiring another young company from a trusted partner.